Latent Autoimmune Diabetes in Adults (LADA) is a type of diabetes that is sometimes referred to as “Type 1.5 diabetes”. LADA is similar to Type 1 diabetes in that it is an autoimmune disorder, but it is diagnosed in adulthood rather than in childhood or adolescence.
LADA is characterized by the gradual destruction of insulin-producing cells in the pancreas by the body’s immune system. However, unlike Type 1 diabetes, which usually develops quickly and requires insulin therapy immediately, the onset of LADA is more gradual and insulin therapy may not be needed initially.
Symptoms of LADA can include increased thirst and urination, fatigue, blurred vision, and slow-healing sores or infections. These symptoms may develop slowly over time and can be mistaken for other conditions such as Type 2 diabetes.
Diagnosis of LADA typically involves blood tests to measure blood sugar levels and the presence of autoantibodies that are associated with Type 1 diabetes. Treatment for LADA may involve lifestyle changes such as diet and exercise, oral medications to help control blood sugar levels, and eventually, insulin therapy.
As LADA is a progressive condition, individuals with LADA will eventually require insulin therapy to manage their blood sugar levels. However, the timing of this transition can vary depending on the individual and their symptoms.
LADA is a relatively uncommon form of diabetes, and further research is needed to fully understand the condition and develop effective treatments.